Verrica Pharmaceuticals Ownership | Who Owns Verrica Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Verrica Pharmaceuticals Ownership Summary

Verrica Pharmaceuticals is owned by 3.18% institutional investors, 48.69% insiders, and 48.13% retail investors. Caligan partners lp is the largest institutional shareholder, holding 8.67% of VRCA shares. Invesco Dorsey Wright SmallCap Momt ETF is the top mutual fund, with 0.96% of its assets in Verrica Pharmaceuticals shares.

VRCA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Verrica Pharmaceuticals	3.18%	48.69%	48.13%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Caligan partners lp	923.91K	8.67%	$4.89M
Affinity asset advisors	707.34K	6.64%	$3.74M
Cannell capital	685.12K	6.43%	$3.62M
Armistice capital	518.18K	4.86%	$2.74M
Velan capital investment management lp	471.56K	4.43%	$2.49M
Boothbay fund management	280.73K	2.64%	$1.49M
Blackrock	1.13M	2.43%	$8.23M
Vanguard group	138.19K	1.46%	$1.15M
Dafna capital management	153.71K	1.44%	$813.14K
Marshall wace, llp	140.50K	1.32%	$743.23K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Cannell capital	685.12K	2.23%	$3.62M
Velan capital investment management lp	471.56K	1.56%	$2.49M
Caligan partners lp	923.91K	0.33%	$4.89M
Stonepine capital management	99.73K	0.21%	$527.60K
Affinity asset advisors	707.34K	0.19%	$3.74M
Dafna capital management	153.71K	0.18%	$813.14K
Verdad advisers, lp	12.10K	0.07%	$64.00K
Armistice capital	518.18K	0.05%	$2.74M
Boothbay fund management	280.73K	0.02%	$1.49M
Legacy trust	17.23K	0.02%	$91.17K

Top Buyers

Holder	Shares	% Assets	Change
Cannell capital	685.12K	2.23%	685.12K
Geode capital management	138.92K	-	71.26K
Vanguard fiduciary trust	65.10K	0.00%	65.10K
Marshall wace, llp	140.50K	0.00%	55.32K
Squarepoint ops	75.21K	0.00%	41.94K

Top Sellers

Holder	Shares	% Assets	Change
Avoro capital advisors	-	-	-4.00M
Perceptive advisors	-	-	-3.25M
Armistice capital	518.18K	0.05%	-600.74K
Heights capital management	-	-	-351.14K
Propel bio management	-	-	-344.94K

New Positions

Holder	Shares	% Assets	Change	Value
Cannell capital	685.12K	2.23%	685.12K	$3.62M
Vanguard fiduciary trust	65.10K	0.00%	65.10K	$344.38K
Aqr capital management	14.44K	-	14.44K	$10.11K
Verdad advisers, lp	12.10K	0.07%	12.10K	$64.00K
Vanguard global advisers	862.00	-	862.00	$4.56K

Sold Out

Holder	Change
Barclays	-1.00
Group one trading	-3.00
Nelson, van denburg & campbell wealth management group	-4.00
True wealth design	-8.00
Srs capital advisors	-9.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	13	-73.47%	338,440	-93.49%	3	0.11%	4	-85.19%	2	-80.00%
Dec 31, 2025	33	3.13%	2,435,253	-1.39%	25	3.79%	18	157.14%	7	-70.83%
Sep 30, 2025	1	-98.08%	568	-100.00%	-	0.00%	-	-100.00%	-	-100.00%
Jun 30, 2025	52	-27.78%	24,696,020	-16.20%	26	2.70%	23	-41.03%	20	100.00%
Mar 31, 2025	3	-96.25%	9,407,623	-68.57%	18	0.44%	2	-95.12%	-	-100.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Invesco Dorsey Wright SmallCap Momt ETF	409.00K	0.96%	-
Vanguard US Total Market Shares ETF	815.89K	0.89%	-
Vanguard Institutional Extnd Mkt Idx Tr	135.94K	0.79%	-
Vanguard Total Stock Mkt Idx Inv	104.71K	0.61%	51.88K
Fidelity Select Biotechnology	517.63K	0.57%	-112.24K
iShares Russell 2000 ETF	520.96K	0.56%	-
Simplify Propel Opportunities ETF	200.00K	0.44%	-
Fidelity Small Cap Index	385.38K	0.42%	-
Small Cap Core Equity Composite	174.70K	0.41%	-
DWS Small Cap Core S	174.70K	0.41%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 25, 2025	Rosenberg Noah L.	CMO	Buy	$3.72K
Nov 25, 2025	Rosenberg Noah L.	CMO	Buy	$10.00K
Nov 25, 2025	Kirby John J.	Interim CFO	Buy	$15.00K
Nov 25, 2025	Kirby John J.	Interim CFO	Buy	$5.58K
Nov 25, 2025	Zawitz David	Chief Operating Officer	Buy	$42.42K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	12	-
2025 Q2	-	-
2025 Q1	-	1
2024 Q4	12	-
2024 Q3	-	18

VRCA Ownership FAQ

Who Owns Verrica Pharmaceuticals?

Verrica Pharmaceuticals shareholders are primarily institutional investors at 3.18%, followed by 48.69% insiders and 48.13% retail investors. The average institutional ownership in Verrica Pharmaceuticals's industry, Biotech Stocks , is 35.75%, which Verrica Pharmaceuticals falls below.

Who owns the most shares of Verrica Pharmaceuticals?

Verrica Pharmaceuticals’s largest shareholders are Caligan partners lp (923.91K shares, 8.67%), Affinity asset advisors (707.34K shares, 6.64%), and Cannell capital (685.12K shares, 6.43%). Together, they hold 21.75% of Verrica Pharmaceuticals’s total shares outstanding.

Does Blackrock own Verrica Pharmaceuticals?

Yes, BlackRock owns 2.43% of Verrica Pharmaceuticals, totaling 1.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.23M$. In the last quarter, BlackRock increased its holdings by 15.08K shares, a 1.35% change.

Who is Verrica Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Cannell capital is Verrica Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.23% of its assets in 685.12K Verrica Pharmaceuticals shares, valued at 3.62M$.

Who is the top mutual fund holder of Verrica Pharmaceuticals shares?

Invesco Dorsey Wright SmallCap Momt ETF is the top mutual fund holder of Verrica Pharmaceuticals shares, with 0.96% of its total shares outstanding invested in 409K Verrica Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools